S7: E4 CAR-T Cell Therapy
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
S7: E4 CAR-T Cell Therapy
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Chimeric antigen receptor (CAR)-T cell therapy has made impressive advancements in treating patients with blood cancers, such as leukemia and lymphoma, for more than a decade now. In this episode, we traverse the challenges and innovations of cell immunotherapy and better understand the design behind these logic-gated, genetically engineered cytotoxic cells with Dr. Yvonne Chen, a leading expert in the field. Dr. Chen is an incredibly accomplished Professor of the MIMG and CBE departments at UCLA and currently leads a Phase 1 Clinical Trial (NCT04007029) using bispecific anti-CD19/anti-CD20 CAR-T cells to treat patients with B cell malignancies.
For more information on Dr. Chen’s research: http://yvchen.bol.ucla.edu/.
Music: https://pixabay.com/music/id-112777/
Episode Team:
Guests - Dr. Yvonne Chen
Host - Brenda Ji
Script Writers - Brenda Ji
Audio - Daniel Nguyen
Producers - Artin Allahverdian, Sonali Joshi
Director - Vy Han, MD